Status: Not yet recruiting

Voll Non-Degradable Shoulder Spacer FIH Study

The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Participants needed: 10

Trial details

Age: 50+Biological sex: AllType: InterventionalSponsor: Voll Medical Technologies Ltd.Updated: Aug 4, 2026Locations: 1

Eligibility criteria

Full thickness MRCT. [+1]

Documented evidence of a history of drug/alcohol abuse within 1 year of enrollme... [+1]

Status: Recruiting

Voll Degradable Shoulder Spacer FIH Study

The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Participants needed: 20